iRhythm Technologies Inc (IRTC)

Currency in USD
109.20
+1.53(+1.42%)
Closed·
109.200.00(0.00%)
·
Earnings results expected in 11 days
IRTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
106.39109.84
52 wk Range
100.85212.00
Key Statistics
Prev. Close
107.67
Open
109.12
Day's Range
106.39-109.84
52 wk Range
100.85-212
Volume
317.85K
Average Volume (3m)
577.05K
1-Year Change
-18.6168%
Book Value / Share
4.99
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IRTC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
177.07
Upside
+62.15%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

iRhythm Technologies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Analyst Ratings

15 Buy
0 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 177.07
(+62.15% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stephens
Buy160.00+46.52%-New CoverageJul 22, 2026
Truist Securities
Buy160.00+46.52%174.00MaintainJul 16, 2026
Baird
Buy160.00+46.52%175.00MaintainJul 14, 2026
Canaccord
Buy152.00+39.19%180.00MaintainJun 01, 2026
Evercore ISI
Buy160.00+46.52%170.00MaintainMay 01, 2026

iRhythm Technologies Inc Earnings Call Summary for Q1/2026

  • iRhythm Q1 2026 EPS of -$0.43 beat estimates by 34.85%; revenue of $199.4M exceeded forecasts, up 25.7% YoY with gross margin expanding to 70.9%.
  • Stock surged 6.96% to $120.75 post-earnings, reflecting investor confidence in operational execution and improved profitability metrics.
  • Company raised full-year 2026 revenue guidance to $875M-$885M, projecting 17%-18% growth with continued margin expansion expected.
  • Adjusted EBITDA reached $14.1M (7.1% of revenue); management cited strong volume growth and operational efficiencies driving performance.
  • Zio MCT launch planned for first-half 2027; executives expressed confidence in regulatory compliance despite ongoing FDA reviews and competitive pressures.
Last Updated: 2026-04-30, 05:52 p/m
Read Full Transcript

Earnings

Latest Release
Apr 30, 2026
EPS / Forecast
-0.43 / -0.66
Revenue / Forecast
199.4M / 194.08M
EPS Revisions
Last 90 days

IRTC Income Statement

Compare IRTC to Peers and Sector

Metrics to compare
IRTC
Peers
Sector
Relationship
P/E Ratio
−129.2x−2.0x−0.3x
PEG Ratio
−1.78−0.080.00
Price/Book
22.3x3.5x2.6x
Price / LTM Sales
4.6x2.1x2.9x
Upside (Analyst Target)
62.5%91.7%57.8%
Fair Value Upside
Unlock24.5%9.5%Unlock

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
16.95M51.58%1.85B
Other Institutional Investors
19.30M48.42%2.11B
Public Companies & Retail Investors
0.000.00%0.00
Total
36.25M100.00%3.96B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.34%2,741,505299,372
Vanguard Portfolio Management, LLC5.47%1,796,372196,164

People Also Watch

63.20
DK
-2.44%
214.07
STE
+1.63%
544.51
MDGL
+0.21%
80.07
HCC
-1.21%
95.36
CORT
-1.34%

FAQ

What Is the iRhythm Tech (IRTC) Stock Price Today?

The iRhythm Tech stock price today is 109.20 USD.

What Stock Exchange Does iRhythm Tech Trade On?

iRhythm Tech is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for iRhythm Tech?

The stock symbol for iRhythm Tech is "IRTC."

What Is the iRhythm Tech Market Cap?

As of today, iRhythm Tech market cap is 3.59B USD.

What Is iRhythm Tech's Earnings Per Share (TTM)?

The iRhythm Tech EPS (TTM) is -0.86.

When Is the Next iRhythm Tech Earnings Date?

iRhythm Tech will release its next earnings report on Aug 06, 2026.

From a Technical Analysis Perspective, Is IRTC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has iRhythm Tech Stock Split?

iRhythm Tech has split 0 times.

How Many Employees Does iRhythm Tech Have?

iRhythm Tech has 2400 employees.

What is the current trading status of iRhythm Tech (IRTC)?

As of Jul 26, 2026, iRhythm Tech (IRTC) is trading at a price of 109.20 USD, with a previous close of 107.67 USD. The stock has fluctuated within a day range of 106.39 USD to 109.84 USD, while its 52-week range spans from 100.85 USD to 212.00 USD.

What Is iRhythm Tech (IRTC) Price Target According to Analysts?

The average 12-month price target for iRhythm Tech is 177.07 USD, with a high estimate of 255 USD and a low estimate of 150 USD. 15 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +62.15% Upside potential.

What Is the IRTC Premarket Price?

IRTC's last pre-market stock price is 108.13 USD. The pre-market share volume is 6,750.00, and the stock has decreased by 0.46, or 0.43%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.